[Changes in respiratory and peripheral muscle function in asthmatic children: effects of inhaled corticoids]

J Díaz Ledo1, R M Busquets Monge, O García-Algar

  • 1Unidad de Neumología y Alergia Pediátrica, Servicio de Pediatría, Hospital del Mar, Barcelona, España.

Insights

Inhaled corticosteroids did not impair respiratory or peripheral muscle function in children with asthma. Asthmatic children showed signs of respiratory muscle adaptation, particularly in inspiratory muscles.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Muscle Physiology
  • Pharmacological Effects in Asthma

Context:

  • Childhood asthma is a prevalent chronic condition.
  • Asthma exacerbations impose mechanical stress on respiratory muscles.
  • Inhaled corticosteroids (ICS) are a primary treatment for persistent asthma.

Purpose:

  • To assess respiratory and peripheral muscle function in children with asthma treated with ICS.
  • To investigate potential associations between muscle function and respiratory function in pediatric asthma.
  • To determine the impact of long-term ICS use on muscle status.

Summary:

  • A study compared 12 asthmatic children (on ICS for ≥2 years) with 7 healthy controls.
  • Evaluations included spirometry, lung volumes, airway resistance, muscle pressures, peripheral function, and body composition.
  • Asthmatic children exhibited air trapping and hyperinflation but similar peripheral muscle function and anthropometrics; they had higher maximum inspiratory pressures.

Impact:

  • Findings suggest ICS do not negatively affect respiratory or peripheral muscle function in pediatric asthma.
  • Evidence indicates respiratory muscle adaptation to chronic asthma-related overload.
  • This adaptation appears specific to inspiratory muscles, suggesting a localized 'training effect'.
Abstract

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...